Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boaz Nachmias

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Haematologica|September 4, 2025
Beating the STATs: targeting the metabolome in acute myeloid leukemiaBoaz Nachmias, Ofir Wolach
Haematologica|September 25, 2025
Gatekeepers of mitochondrial metabolism: the emerging role of the SLC25 family in leukemiaArnon Haran, Boaz Nachmias
Leukemia|July 7, 2020
Targeting nuclear import and export in hematological malignanciesBoaz Nachmias, Aaron D Schimmer
Cancer Cell|November 14, 2018
Metabolic Flexibility in Leukemia-Adapt or DieBoaz Nachmias, Aaron D Schimmer
British Journal of Haematology|June 6, 2022
Mesenchymal stroma/stem cells: Haematologists' friend or foe?Boaz Nachmias, Eran Zimran, Batia Avni
Diagnostics (Basel, Switzerland)|March 6, 2021
Diagnostic and Management Difficulty of Bleeding Aorto-Duodenal Fistula Associated with Hodgkin's LymphomaBoaz Nachmias, Allan I Bloom, Alexander Gural
Seminars in Cancer Biology|June 29, 2004
The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancerBoaz Nachmias, Yaqoub Ashhab, Dina Ben-Yehuda
British Journal of Haematology|January 31, 2024
Venetoclax resistance in acute myeloid leukaemia-Clinical and biological insightsBoaz Nachmias, Shlomzion Aumann, Arnon Haran, et al.
British Journal of Haematology|August 31, 2025
Measurable residual disease-guided therapy in acute myeloid leukaemia: Practical insightsBoaz Nachmias, Arnon Haran, Meira Yisraeli Salman, et al.
Acta Haematologica|May 26, 2023
Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis in High-Risk Hemato-Oncology PatientsRozan Sabbah, Maya Korem, Adir Shaulov, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Haematologica|September 4, 2025
Beating the STATs: targeting the metabolome in acute myeloid leukemiaBoaz Nachmias, Ofir Wolach
Haematologica|September 25, 2025
Gatekeepers of mitochondrial metabolism: the emerging role of the SLC25 family in leukemiaArnon Haran, Boaz Nachmias
Leukemia|July 7, 2020
Targeting nuclear import and export in hematological malignanciesBoaz Nachmias, Aaron D Schimmer
Cancer Cell|November 14, 2018
Metabolic Flexibility in Leukemia-Adapt or DieBoaz Nachmias, Aaron D Schimmer
British Journal of Haematology|June 6, 2022
Mesenchymal stroma/stem cells: Haematologists' friend or foe?Boaz Nachmias, Eran Zimran, Batia Avni
Diagnostics (Basel, Switzerland)|March 6, 2021
Diagnostic and Management Difficulty of Bleeding Aorto-Duodenal Fistula Associated with Hodgkin's LymphomaBoaz Nachmias, Allan I Bloom, Alexander Gural
Seminars in Cancer Biology|June 29, 2004
The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancerBoaz Nachmias, Yaqoub Ashhab, Dina Ben-Yehuda
British Journal of Haematology|January 31, 2024
Venetoclax resistance in acute myeloid leukaemia-Clinical and biological insightsBoaz Nachmias, Shlomzion Aumann, Arnon Haran, et al.
British Journal of Haematology|August 31, 2025
Measurable residual disease-guided therapy in acute myeloid leukaemia: Practical insightsBoaz Nachmias, Arnon Haran, Meira Yisraeli Salman, et al.
Acta Haematologica|May 26, 2023
Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis in High-Risk Hemato-Oncology PatientsRozan Sabbah, Maya Korem, Adir Shaulov, et al.
Pageof 6